462 related articles for article (PubMed ID: 18299113)
21. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
22. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
[TBL] [Abstract][Full Text] [Related]
23. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection.
Peddada AV; Jennings SB; Faricy PO; Walsh RA; White GA; Monroe AT
J Urol; 2007 Nov; 178(5):1963-7. PubMed ID: 17868718
[TBL] [Abstract][Full Text] [Related]
24. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
Makarewicz R
Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
[TBL] [Abstract][Full Text] [Related]
25. Interstitial brachytherapy in soft tissue sarcomas: the Rambam experience.
Rosenblatt E; Meushar N; Bar-Deroma R; Drumea K; Stein M; Zidan J; Kuten A
Isr Med Assoc J; 2003 Aug; 5(8):547-51. PubMed ID: 12929290
[TBL] [Abstract][Full Text] [Related]
26. Sublobar versus lobar resection: current status.
Narsule CK; Ebright MI; Fernando HC
Cancer J; 2011; 17(1):23-7. PubMed ID: 21263263
[TBL] [Abstract][Full Text] [Related]
27. [Perioperative targeting brachytherapy for lung cancer invading the chest wall].
Takizawa M; Oda M; Ohta Y; Kawakami K; Tsunezuka Y; Matsumoto I; Tamura M; Yachi T; Watanabe G; Takanaka T; Nishijima H; Matsui O
Kyobu Geka; 2004 Dec; 57(13):1198-201. PubMed ID: 15609656
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
29. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer.
d'Amato TA; Galloway M; Szydlowski G; Chen A; Landreneau RJ
Chest; 1998 Oct; 114(4):1112-5. PubMed ID: 9792585
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
[TBL] [Abstract][Full Text] [Related]
32. The role of radiation therapy after incomplete resection of penile cancer.
Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
[TBL] [Abstract][Full Text] [Related]
33. Potential decreased morbidity of interstitial brachytherapy for gynecologic malignancies using laparoscopy: A pilot study.
Choi JC; Ingenito AC; Nanda RK; Smith DH; Wuu CS; Chin LJ; Schiff PB
Gynecol Oncol; 1999 May; 73(2):210-5. PubMed ID: 10329036
[TBL] [Abstract][Full Text] [Related]
34. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
35. [Intraoperative radiotherapy of lung cancer. Report of 31 cases].
Sun YE
Zhonghua Wai Ke Za Zhi; 1991 Jun; 29(6):379-81, 398. PubMed ID: 1657553
[TBL] [Abstract][Full Text] [Related]
36. Robotic brachytherapy and sublobar resection for T1 non-small cell lung cancer in high-risk patients.
Blasberg JD; Belsley SJ; Schwartz GS; Evans A; Wernick I; Ashton RC; Bhora FY; Connery CP
Ann Thorac Surg; 2010 Feb; 89(2):360-7. PubMed ID: 20103299
[TBL] [Abstract][Full Text] [Related]
37. CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC).
Martínez-Monge R; Pagola M; Vivas I; López-Picazo JM
Lung Cancer; 2008 Aug; 61(2):209-13. PubMed ID: 18243409
[TBL] [Abstract][Full Text] [Related]
38. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience.
Brabham JG; Cardenes HR
Am J Clin Oncol; 2009 Aug; 32(4):417-22. PubMed ID: 19451799
[TBL] [Abstract][Full Text] [Related]
39. Role of adjuvant radiation (external beam/brachytherapy) for stage I NSCLC.
Ketchedjian A; DiPetrillo TA; Daly B; Fernando HC
Thorac Surg Clin; 2007 May; 17(2):273-8. PubMed ID: 17626405
[TBL] [Abstract][Full Text] [Related]
40. Surgical resection for lung cancer with infiltration of the thoracic aorta.
Ohta M; Hirabayasi H; Shiono H; Minami M; Maeda H; Takano H; Miyoshi S; Matsuda H
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):804-8. PubMed ID: 15821646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
